These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 18280641

  • 21. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
    Fritzmann J, Morkel M, Besser D, Budczies J, Kosel F, Brembeck FH, Stein U, Fichtner I, Schlag PM, Birchmeier W.
    Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
    [Abstract] [Full Text] [Related]

  • 22. Regulation of prostasin expression and function in the prostate.
    Chen LM, Zhang X, Chai KX.
    Prostate; 2004 Apr 01; 59(1):1-12. PubMed ID: 14991861
    [Abstract] [Full Text] [Related]

  • 23. Vitamin D3 modulated gene expression patterns in human primary normal and cancer prostate cells.
    Guzey M, Luo J, Getzenberg RH.
    J Cell Biochem; 2004 Oct 01; 93(2):271-85. PubMed ID: 15368355
    [Abstract] [Full Text] [Related]

  • 24. Gene expression profile of mouse prostate tumors reveals dysregulations in major biological processes and identifies potential murine targets for preclinical development of human prostate cancer therapy.
    Haram KM, Peltier HJ, Lu B, Bhasin M, Otu HH, Choy B, Regan M, Libermann TA, Latham GJ, Sanda MG, Arredouani MS.
    Prostate; 2008 Oct 01; 68(14):1517-30. PubMed ID: 18668517
    [Abstract] [Full Text] [Related]

  • 25. [Expression of PIAS3 an inhibitor of activated STAT3 protein in human prostate cancer].
    Gan L, Yin ZF, Li M.
    Zhonghua Yi Xue Za Zhi; 2008 Feb 05; 88(6):419-21. PubMed ID: 18581899
    [Abstract] [Full Text] [Related]

  • 26. Lithium suppresses cell proliferation by interrupting E2F-DNA interaction and subsequently reducing S-phase gene expression in prostate cancer.
    Sun A, Shanmugam I, Song J, Terranova PF, Thrasher JB, Li B.
    Prostate; 2007 Jun 15; 67(9):976-88. PubMed ID: 17440966
    [Abstract] [Full Text] [Related]

  • 27. [Mechanism of inhibiting the proliferation of prostate cancer by finasteride: a study using cDNA microarray].
    Chen G, Geng J, Zhang YF.
    Zhonghua Yi Xue Za Zhi; 2005 Jun 08; 85(21):1489-92. PubMed ID: 16061029
    [Abstract] [Full Text] [Related]

  • 28. Sympathectomy suppresses tumor growth and alters gene-expression profiles in rat tongue cancer.
    Raju B, Hultström M, Haug SR, Ibrahim SO, Heyeraas KJ.
    Eur J Oral Sci; 2009 Aug 08; 117(4):351-61. PubMed ID: 19627344
    [Abstract] [Full Text] [Related]

  • 29. Expression of nerve growth factor and tyrosine kinase receptor A and correlation with perineural invasion in pancreatic cancer.
    Ma J, Jiang Y, Jiang Y, Sun Y, Zhao X.
    J Gastroenterol Hepatol; 2008 Dec 08; 23(12):1852-9. PubMed ID: 19120874
    [Abstract] [Full Text] [Related]

  • 30. Doxazosin induces apoptosis in LNCaP prostate cancer cell line through DNA binding and DNA-dependent protein kinase down-regulation.
    Arencibia JM, Del Rio M, Bonnin A, Lopes R, Lemoine NR, López-Barahona M.
    Int J Oncol; 2005 Dec 08; 27(6):1617-23. PubMed ID: 16273218
    [Abstract] [Full Text] [Related]

  • 31. Differential effects of cholesterol and phytosterols on cell proliferation, apoptosis and expression of a prostate specific gene in prostate cancer cell lines.
    Ifere GO, Barr E, Equan A, Gordon K, Singh UP, Chaudhary J, Igietseme JU, Ananaba GA.
    Cancer Detect Prev; 2009 Dec 08; 32(4):319-28. PubMed ID: 19186008
    [Abstract] [Full Text] [Related]

  • 32. Small interfering RNA-directed targeting of Toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicity.
    Hua D, Liu MY, Cheng ZD, Qin XJ, Zhang HM, Chen Y, Qin GJ, Liang G, Li JN, Han XF, Liu DX.
    Mol Immunol; 2009 Sep 08; 46(15):2876-84. PubMed ID: 19643479
    [Abstract] [Full Text] [Related]

  • 33. Regulation of growth hormone receptors in human prostate cancer cell lines.
    Bidosee M, Karry R, Weiss-Messer E, Barkey RJ.
    Mol Cell Endocrinol; 2009 Oct 15; 309(1-2):82-92. PubMed ID: 19540305
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Suppression of growth and tumorigenicity in the prostate tumor cell line M12 by overexpression of the transcription factor SOX9.
    Drivdahl R, Haugk KH, Sprenger CC, Nelson PS, Tennant MK, Plymate SR.
    Oncogene; 2004 Jun 03; 23(26):4584-93. PubMed ID: 15077158
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Differential gene expression signature between primary and metastatic head and neck squamous cell carcinoma.
    Liu CJ, Liu TY, Kuo LT, Cheng HW, Chu TH, Chang KW, Lin SC.
    J Pathol; 2008 Mar 03; 214(4):489-97. PubMed ID: 18213732
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Functional angiotensin II type 2 receptors inhibit growth factor signaling in LNCaP and PC3 prostate cancer cell lines.
    Chow L, Rezmann L, Imamura K, Wang L, Catt K, Tikellis C, Louis WJ, Frauman AG, Louis SN.
    Prostate; 2008 May 01; 68(6):651-60. PubMed ID: 18288685
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.